Cadre Holdings, Inc. CDRE 深 沪
等待开盘 04-03 09:30:00 美东时间
32.51
+0.340
+1.06%
华盛通- 最 高32.70
- 今 开31.02
- 成交量 50.35万股
- 最 低 30.86
- 昨 收 32.17
- 总市值 13.89亿
- 52周最高 48.7599
- 市盈率 静 31.99
- 换手率 1.18%
- 52周最低 28.025
- 委 比 50.00%
- 总股本 4272.66万
- 历史最高 48.7599
- 量 比 1.37
- 振 幅 5.72%
- 历史最低 12.61
- 每 手 1
- 风险率 5.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股周涨跌榜 | 与诺和诺德“世纪大和解”！Hims周内暴涨超57%；PayPay上市两日涨超32%
与诺和诺德“世纪大和解”！Hims周内暴涨超57%；近十年日企赴美最大IPO，PayPay上市两日涨超32%；获英伟达20亿美元投资，Nebius周涨超26%>>
03-14 10:29
Cadre Hldgs Earnings Report: Q4 Overview
Cadre Hldgs (NYSE:CDRE) released its Q4 earnings on Tuesday, March 10, 2026 at ...
03-11 05:30
Cadre Hldgs Sees FY2026 Sales $736.000M-$758.000M vs $728.768M Est
Cadre Hldgs (NYSE:CDRE) sees FY2026 sales of $736.000 million-$758.000 million vs $728.768 million analyst estimate.
03-11 04:16
Cadre Hldgs Q4 EPS $0.27 Misses $0.38 Estimate, Sales $167.224M Miss $182.943M Estimate
Cadre Hldgs (NYSE:CDRE) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.38 by 29.5 percent. This is a 15.62 percent decrease over earnings of $0.32 per share from the same
03-11 04:15
Cadre Holdings Subsidiary Awarded $86.4M Contracts By General Dynamics European Land Systems To Offer Blast Attenuation Seats
Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "the Company") announced today that its subsidiary Med-Eng, LLC has been awarded two contracts with values of $74.6 million and $11.8 million by General Dynamics European
03-10 19:46
Earnings Scheduled For March 10, 2026
Companies Reporting Before The Bell • Ultralife (NASDAQ:ULBI) is likely to repo...
03-10 19:11
What's Next: Cadre Hldgs's Earnings Preview
Cadre Hldgs (NYSE:CDRE) is set to give its latest quarterly earnings report on ...
03-09 23:01
Defense Stocks Hit Records As Trump Warns 'Big Wave' In Iran: 10 Names In Focus
Defense stocks hit record highs as Trump warns the "big wave" in Iran is still ahead. XAR climbs 3.6% while RCAT, NOC, BWXT and others rally on expectations of a sustained military campaign.
03-03 00:44
美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
Roth Capital Maintains Buy on Cadre Hldgs, Raises Price Target to $50
Roth Capital analyst Matt Koranda maintains Cadre Hldgs (NYSE:CDRE) with a Buy and raises the price target from $49 to $50.
02-04 00:32
